1302P MET×MET bispecific antibody davutamig (REGN5093) for MET-altered advanced non-small cell lung cancer (aNSCLC): Update from a first-in-human (FIH) study
2024 · Annals of Oncology · 4 citations
https://doi.org/10.1016/j.annonc.2024.08.1359
B
B.C. Cho
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
0
Papers
0
Citations
B.C. Cho is an academic researcher.
Papers by this author
worksChat about Author
Papers
Chat
Click to start Chat